BioNano Genomics Inc (BNGO)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

9540 TOWNE CENTRE DRIVE SAN DIEGO, CA 92121

Data as of 2018-11-01 12:29:05 -0400
Market Cap0 Shares Outstanding0 Avg 30-day Volume
P/E Ratio Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA0
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash0 Current Debt Gross Profit0
BETA0.0 52-week High/Low8.0 / 5.4 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from BNGO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BNGO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BNGO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OLDAKOWSKI MARK CHIEF OPERATING OFFICER

  • Officer
275,000 2021-04-01 1

HOLMLIN R. ERIK PRESIDENT AND CEO

  • Officer
  • Director
775,000 2021-04-01 1

CHAUBEY ALKA CHIEF MEDICAL OFFICER

  • Officer
275,000 2021-04-01 5

STEWART CHRISTOPHER P. CHIEF FINANCIAL OFFICER

  • Officer
275,000 2021-04-01 4

BARKER DAVID L

  • Director
0 2020-06-30 1

LUDERER ALBERT

  • Director
0 2020-06-30 1

TWOMEY CHRISTOPHER J

  • Director
0 2020-06-30 1

VUORI KRISTIINA MD

  • Director
0 2020-06-30 1

LINNEY YVONNE

  • Director
0 2020-06-30 1

MAMUSZKA HANNAH

  • Director
0 2020-06-30 1

ROBINSON WARREN CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-02-18 0

ADAMS HEATHER CHIEF ADMINISTRATIVE OFFICER

  • Officer
0 2020-02-18 0

CAI DARREN

  • Director
0 2019-06-06 0

WANG JUNFENG

  • Director
  • 10% Owner
0 2019-06-06 0

ZHOU QUAN

  • Director
  • 10% Owner
0 2019-06-06 0

WARD MICHAEL JAMES FORMER CHIEF FINANCIAL OFFICER

  • Officer
0 2019-03-01 0

BORODKIN MARK CHIEF OPERATING OFFICER

BORODKIN MARK CHIEF OPERATING OFFICER

  • Officer
6,815 2019-01-18 1

DOMAIN PARTNERS VIII, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
943,878 2018-08-23 0

DP VIII ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
6,891 2018-08-23 0

CAO HAN PHD CHIEF SCIENTIFIC OFFICER

  • Officer
112,936 2018-08-23 0

ROSY SHINE LTD

  • 10% Owner
1,134,000 2018-08-23 0

LC FUND VI, L.P.

LC PARALLEL FUND VI, L.P.

ROSY SHINE LTD

  • 10% Owner
2,906,915 2018-08-23 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • 10% Owner
140 2018-08-21 0

LC FUND VI, L.P.

LC HEALTHCARE FUND I, L.P.

LC PARALLEL FUND VI, L.P.

  • 10% Owner
0 2018-08-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

STEWART CHRISTOPHER P. - Officer CHIEF FINANCIAL OFFICER

2021-04-02 18:33:12 -0400 2021-04-01 A 275,000 a 275,000 direct

OLDAKOWSKI MARK - Officer CHIEF OPERATING OFFICER

2021-04-02 18:31:21 -0400 2021-04-01 A 275,000 a 275,000 direct

HOLMLIN R. ERIK - Director - Officer PRESIDENT AND CEO

2021-04-02 18:32:20 -0400 2021-04-01 A 775,000 a 775,000 direct

CHAUBEY ALKA - Officer CHIEF MEDICAL OFFICER

2021-04-02 18:33:59 -0400 2021-04-01 A 275,000 a 275,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments